Patent Assignment
Reel/Frame 068933/0401
Assignment of Assignor's Interest
Recorded: 2024-10-17
Pages: 9
Assignors
DILUZIO, WILLOW
Executed: 2012-07-03
NGUYEN, PHUONG M.
Executed: 2012-07-03
VARGA, CSANAD M.
Executed: 2012-07-03
PALANIAPPAN, VAITHIANATHAN
Executed: 2012-07-03
BROWN, JASON
Executed: 2012-07-03
FOX, IRVING H.
Executed: 2012-07-03
SCHOLZ, CATHERINE
Executed: 2012-07-03
ROSARIO, MARIA
Executed: 2012-07-03
Assignee
MILLENNIUM PHARMACEUTICALS, INC.
40 LANDSDOWNE STREET, CAMBRIDGE, MASSACHUSETTS, 02139
Covered Properties
(3)
Formulation for Anti-ALPHA4BETA7 Antibody
Application:
15/983,791 →
Publication:
US 2018/0327497
Formulation for Anti-ALPHA4BETA7 Antibody
Application:
16/009,865 →
Publication:
US 2018/0346578
Formulation for Anti-ALPHA4BETA7 Antibody
Application:
18/912,587 →
Publication:
US 2025/0034263
Related Assignments
(4)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Oct 17, 2024
From: JENKINS, HELEN
To: TAKEDA GLOBAL RESEARCH & DEVELOPMENT CENTER (EUROPE), LTD.
Reel/Frame 068933/0431 →
Assignment of Assignor's Interest
Oct 17, 2024
From: MILLENNIUM PHARMACEUTICALS, INC.
To: TAKEDA PHARMACEUTICAL COMPANY LIMITED
Reel/Frame 068933/0474 →
Assignment of Assignor's Interest
Oct 17, 2024
From: TAKEDA GLOBAL RESEARCH & DEVELOPMENT CENTRE (EUROPE) LTD.
To: TAKEDA PHARMACEUTICAL COMPANY LIMITED
Reel/Frame 068933/0437 →
Assignment of Assignor's Interest
Oct 17, 2024
From: TAKEDA PHARMACEUTICAL COMPANY LIMITED
To: MILLENNIUM PHARMACEUTICALS, INC.
Reel/Frame 068933/0459 →